We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

164 hedge funds and large institutions have $381M invested in Anika Therapeutics in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 58

2.83% less ownership

Funds ownership: 95.72% → 92.89% (-2.8%)

14% less funds holding

Funds holding: 191 → 164 (-27)

46% less capital invested

Capital invested by funds: $708M → $381M (-$327M)

55% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 42

62% less call options, than puts

Call options by funds: $1.83M | Put options by funds: $4.83M

Holders
164
Holders Change
-27
Holders Change %
-14.14%
% of All Funds
3.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
57
Reduced
58
Closed
42
Calls
$1.83M
Puts
$4.83M
Net Calls
-$3M
Net Calls Change
+$12.7M

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$6.8M
2
Renaissance Technologies
Renaissance Technologies
New York
+$6.58M
3
BTW
Boston Trust Walden
Massachusetts
+$4.31M
4
Los Angeles Capital Management
Los Angeles Capital Management
California
+$3.63M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$3.4M

Top Sellers

Rank Fund Capital Flow
1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$5.22M
2
Morgan Stanley
Morgan Stanley
New York
-$4.36M
3
MCM
Matarin Capital Management
New York
-$4M
4
N
Nuveen
North Carolina
-$3.94M
5
Goldman Sachs
Goldman Sachs
New York
-$3.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
Los Angeles Capital Management
26
Los Angeles Capital Management
California
$2.81M +$3.63M +89,779 +1,198%
CM
27
Capital Management
Virginia
$2.69M +$1.75M +43,193 +87%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$2.65M -$967K -23,900 -21%
Citadel Advisors
29
Citadel Advisors
Florida
$2.62M -$925K -22,876 -20%
Arrowstreet Capital
30
Arrowstreet Capital
Massachusetts
$2.25M -$5.22M -129,070 -62%
WG
31
Winton Group
United Kingdom
$2.11M -$752K -18,592 -20%
FP
32
Foundry Partners
Minnesota
$1.84M +$1.56M +38,680 +155%
Millennium Management
33
Millennium Management
New York
$1.71M -$1.49M -36,778 -38%
Russell Investments Group
34
Russell Investments Group
United Kingdom
$1.68M +$262K +6,469 +12%
Stifel Financial
35
Stifel Financial
Missouri
$1.65M -$798K -19,725 -26%
Morgan Stanley
36
Morgan Stanley
New York
$1.64M -$4.36M -107,807 -66%
Nomura Holdings
37
Nomura Holdings
Japan
$1.62M +$1.84M +45,500 +433%
N
38
Nuveen
North Carolina
$1.54M -$3.94M -97,303 -65%
JG
39
Jefferies Group
New York
$1.47M +$1.52M +37,657 +273%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$1.45M +$101K +2,507 +5%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$1.4M +$100K +2,483 +5%
ETM
42
Euclidean Technologies Management
Washington
$1.23M +$1.71M +42,375 New
Fisher Asset Management
43
Fisher Asset Management
Washington
$1.18M -$166K -4,113 -9%
JMPWA
44
JP Morgan Private Wealth Advisors
California
$1.14M +$324 +8 +0%
Legal & General Group
45
Legal & General Group
United Kingdom
$1.07M +$7.77K +192 +0.5%
PPA
46
Parametric Portfolio Associates
Washington
$957K -$859K -21,225 -39%
MCM
47
Matarin Capital Management
New York
$942K -$4M -98,866 -75%
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$932K +$1.16M +28,747 +822%
SEI Investments
49
SEI Investments
Pennsylvania
$927K +$404K +9,990 +44%
Public Sector Pension Investment Board (PSP Investments)
50
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$923K – – –
1
2
3 4 5

ANIK Hedge Fund Activity: Q1 2020 in Review

164 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q1 2020, worth a combined $381M — down 46% from $708M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of ANIK and 19 opened new positions — a net loss of 23 holders — while 58 trimmed existing stakes and 57 added.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $6.8M. The largest seller was Arrowstreet Capital, cutting an estimated $5.22M.

  • 164 institutional investors held Anika Therapeutics (ANIK) as of Q1 2020, down from 191 in Q4 2019.
  • Funds reported $381M of Anika Therapeutics stock for Q1 2020, down 46% quarter-over-quarter.
  • 19 funds opened new Anika Therapeutics positions in Q1 2020 and 42 closed out, a net change of -23 holders.
  • The largest Anika Therapeutics buyer in Q1 2020 was Avidity Partners Management, an estimated $6.8M added.
  • The largest Anika Therapeutics seller in Q1 2020 was Arrowstreet Capital, an estimated $5.22M sold.

Based on aggregated 13F filings for Q1 2020.